2494
K. N. Gavrilov et al. / Tetrahedron: Asymmetry 20 (2009) 2490–2496
Table 5
substrate 6 with dimethyl malonate were performed according to
Rh-catalysed addition of phenylboronic acid to 2-methoxybenzaldehydea
the appropriate procedures.7a,18–21 The Rh-catalysed hydrogena-
tion of
a-dehydrocarboxylic acid esters 8a–c was performed as
O
published.22,23 The Rh-catalysed addition of phenylboronic acid
to 2-methoxybenzaldehyde 10 was performed according to the
known procedure.24 Conversion of substrate 10 and ee of product
11 were determined using HPLC (Daicel Chiralcel OD-H column)
according to the literature.15b,24 Starting substrates 4, 6 and 8b
were synthesised as published.16,25,26 Dimethyl malonate, BSA
(N,O–bis(trimethylsilyl) acetamide), sodium para-toluene sulfi-
nate, dimethyl itaconate, methyl 2-acetamidoacrylate, 2-methoxy-
benzaldehyde, phenylboronic acid and [Rh(C2H4)2Cl]2 were
purchased from Aldrich and Acros Organics and used without
further purification.
O
OH
O
PhB(OH)2, [Rh(C2H4)2Cl]2/ 2L
*
1,4-dioxane/H2O
10
11
Entry
Ligand
Conv.b (%)
ee (%)
1
2
(SC,RP)-3
(RC,SP)-3
72 (63)c
100
65 (S)
3 (R)
a
All reactions were carried out with 1 mol % of [Rh(C2H4)2Cl]2 at room temper-
ature for 48 h (KFꢄ2H2O).
b
The conversion of the substrate 10 and enantiomeric excess of 11 were deter-
4.2. General procedure for the synthesis of ligands (SC,RP)-3 and
(RC,SP)-3
mined by HPLC (Daicel Chiralcel OD-H, C6H14/i-PrOH = 9/1, 1 ml/min, 230 nm,
t(S) = 14 min, t(R) = 14.3 min).
c
Isolated yield of 11 is given in brackets.
A solution of compound 2 (1.11 g, 5 mmol) in THF (15 ml)
was added dropwise at 20 °C over 20 min to a vigorously stirred
solution of (SC,RP)-1 or (RC,SP)-1 (2.41 g, 10 mmol) and Et3N (1.45
ml, 10.4 mmol) in THF (30 ml). The mixture was then heated to
the boiling point, stirred for 1.5 h, cooled to 20 °C and filtered.
The filtrate was concentrated in vacuo (40 Torr). The residue
was purified by flash chromatography on silica gel (hexane/
AcOEt 1:2).
mentary to each other in enantioselective catalysis. Inversion of the
*
absolute configuration at the C (50) stereocentre and, as a result, at
the P*(20) stereocentre in the phosphabicyclic frameworks of the
novel ligands allows us to control the degree and direction of asym-
metric induction. Thus, in each of the tested catalytic reactions,
diastereoisomeric ligands afforded products with opposite absolute
configurations. Furthermore, in the Pd-catalysed allylic sulfonyla-
tion of (E)-1,3-diphenylallyl acetateand inthe Rh-catalysed addition
of phenylboronic acid to 2-methoxybenzaldehyde, natural diaste-
reomer (SC,RP)-3 is a more efficient stereoselector; however, in the
Pd-catalysed allylic alkylation of (E)-1,3-diphenylallyl acetate and
cyclohex-2-enyl ethyl carbonate, allylic amination of (E)-1,3-
diphenylallyl acetate and in the Rh-catalysed hydrogenation of
4.2.1. 3,4-Bis[(20R,50S)-30-phenyl-10,30-diaza-20-phosphabicy-
clo[3.3.0]octyloxy]-(3R,4R)-1- benzylpyrrolidine-2,5-dione
(SC,RP)-3
(Hexane/AcOEt 1:2 Rf = 0.80) (2.33 g, yield 74% as yellow pow-
der).
½
a 2D0
ꢃ
¼ ꢁ288:9 (c 1.0, CHCl3). IR (CHCl3):
m(C@O) =
1708 cmꢁ1
.
1H NMR (CDCl3) d: 1.83 (dq, 2H, J = 10.7 Hz), 1.9 (m,
a-dehydrocarboxylic acid esters, unnatural diastereomer (RC,SP)-3
4H), 2.1 (dq, 2H, J = 10.9 Hz), 2.4 (ddd, 2H, J = 8.3, 6.9, 5.7 Hz),
3.1 (m, 4H), 3.6 (m, 4H), 4.68 (m, 4H), 6.65 (d, 4H, J = 7.7 Hz),
7.09 (t, 4H, J = 7.6 Hz), 7.2 (m, 3H), 7.36 (d, 2H, J = 7.7, 7.3 Hz),
7.74 (d, 2H, J = 8.3 Hz). 13C NMR (CDCl3) d: 26.4 [d, 3J = 4.4 Hz,
is superior. Further modifications of the new ligands and their appli-
cations to other asymmetric reactions are currently in progress in
our laboratories.
2
C(70)], 31.9 [s, C(60)], 42.4 (s, CH2N), 48.1 [d, J = 35.0 Hz, C(80)],
2
2
53.8 [d, J = 7.3 Hz, C(40)], 62.9 [d, J = 8.0 Hz, C(50)], 74.7 (s,
4. Experimental
CHO), 115.5 (d, 3J = 13.1 Hz, CHAr), 119.6 (s, CHAr), 128.0 (s, CHAr
,
4.1. General methods
Bn), 128.7 (s, CHAr, Bn), 128.9 (s, CHAr, Bn), 129.2 (s, CHAr), 135.3
(s, CAr, Bn), 145.2 (d, 2J = 16.0 Hz, CAr), 172.4 (s, C@O). MS (MALDI
TOF/TOF), m/z (I, %): 669 (61) [M+K]+, 653 (100) [M+Na]+, 631
(11) [M+H]+, 408 (76) [MꢁC11H15N2OP]+. Anal. Calcd for
C33H37N5O4P2: C, 62.95; H, 5.92; N, 11.12. Found: C, 63.20; H,
5.79; N, 11.22.
IR spectra were recorded on Specord M-80 spectrophotometer
in CHCl3 (NaCl cuvette). 31P, 13C and 1H NMR spectra were re-
corded with a Bruker AMX 400 instrument (162.0 MHz for 31P,
100.6 MHz for 13C and 400.13 MHz for 1H). Complete assignment
of all the resonances in 13C NMR spectra was achieved by the use
of DEPT techniques. Chemical shifts (ppm) are given relative to
4.2.2. 3,4-Bis[(20S,50R)-30-phenyl-10,30-diaza-20-phosphabicyclo-
[3.3.0]octyloxy]-(3R,4R)-1- benzylpyrrolidine-2,5-dione (RC,SP)-
3
Me4Si (1H and 13C) and 85% H3PO4 31P NMR). Mass spectra were
(
recorded with a Bruker Daltonics Ultraflex spectrometer (MALDI
TOF/TOF). Optical rotations were measured on a Perkin–Elmer
341 polarimeter. Elemental analyses were performed at the Labo-
ratory of Microanalysis (Institute of Organoelement Compounds,
Moscow).
(Hexane/AcOEt 1:2 Rf = 0.90) (2.2 g, yield 70% as yellow pow-
der).
½
a 2D0
ꢃ
¼ þ252:4 (c 1.0, CHCl3). IR (CHCl3):
m(C@O) =
1704 cmꢁ1
.
1H NMR (CDCl3) d: 1.86 (dq, 2H, J = 10.3 Hz), 2.1 (m,
4H), 2.2 (dq, 2H, J = 11.1 Hz), 2.4 (ddd, 2H, J = 8.1, 7.0, 5.9 Hz),
3.0 (m, 4H), 3.7 (m, 4H), 4.72 (m, 4H), 6.66 (d, 4H, J = 7.5 Hz),
7.19 (t, 4H, J = 7.6 Hz), 7.3 (m, 3H), 7.41 (d, 2H, J = 7.7, 7.2 Hz),
7.8 (d, 2H, J = 8.2 Hz). 13C NMR (CDCl3) d: 26.6 [d, 3J = 4.4 Hz,
All reactions were carried out under a dry argon atmosphere
in flame-dried glassware and in freshly dried and distilled
solvents; triethylamine, pyrrolidine and dipropylamine were dis-
tilled over KOH and then over a small amount of LiAlH4 before
use. Phosphorylating reagents—(2R,5S)-2-chloro-3-phenyl-1,3-dia-
za-2-phosphabicyclo[3.3.0]octane (SC,RP)-1 and (2S,5R)-2-chloro-3-
phenyl-1,3-diaza-2-phosphabicyclo[3.3.0]octane (RC,SP)-1 were
2
C(70)], 31.5 [s, C(60)], 42.4 (s, CH2N), 48.0 [d, J = 35.0 Hz, C(80)],
2
2
53.7 [d, J = 6.6 Hz, C(40)], 62.8 [d, J = 8.0 Hz, C(50)], 73.7 (s,
CHO), 115.3 (d, 3J = 12.4 Hz, CHAr), 119.5 (s, CHAr), 128.0 (s, CHAr
,
Bn), 128.7 (s, CHAr, Bn), 128.8 (s, CHAr, Bn), 129.2 (s, CHAr), 135.4
(s, CAr, Bn), 145.3 (d, 2J = 17.5 Hz, CAr), 172.9 (s, C@O). MS (MALDI
TOF/TOF), m/z (I, %): 669 (100) [M+K]+, 653 (89) [M+Na]+, 631
(17) [M+H]+, 408 (55) [MꢁC11H15N2OP]+. Anal. Calcd for
C33H37N5O4P2: C, 62.95; H, 5.92; N, 11.12. Found: C, 63.15; H,
6.0; N, 11.0.
16
prepared analogously to the known procedure.7a Pd(allyl)Cl]2 and
17
[Rh(cod)2]BF4 were prepared as described earlier. Pd-catalysed
allylic substitution: sulfonylation of substrate 4 with sodium
para-toluene sulfinate, alkylation with dimethyl malonate, amina-
tion with dipropylamine and pyrrolidine; and alkylation of